National Trends in Recurrent AMI Hospitalizations 1 Year After Acute Myocardial Infarction in Medicare Beneficiaries: 1999–2010
暂无分享,去创建一个
H. Krumholz | S. Chaudhry | Jersey Chen | K. Dharmarajan | Yun Wang | F. Masoudi | J. Dodson | Rabeea F. Khan
[1] N. Wong,et al. Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010). , 2013, The American journal of cardiology.
[2] D. Kolte,et al. ST-elevation myocardial infarction in the elderly--temporal trends in incidence, utilization of percutaneous coronary intervention and outcomes in the United States. , 2013, International journal of cardiology.
[3] S. Normand,et al. Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries: Progress and Continuing Challenges , 2010, Circulation.
[4] R. Goldberg,et al. Disparities in Combination Drug Therapy Use in Older Adults with Coronary Heart Disease , 2010, Drugs & aging.
[5] J. Gore,et al. Contemporary trends in evidence-based treatment for acute myocardial infarction. , 2010, The American journal of medicine.
[6] E. Braunwald,et al. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction , 2009, Journal of the American College of Cardiology.
[7] H. Wedel,et al. Hazard Function and Secular Trends in the Risk of Recurrent Acute Myocardial Infarction: 30 Years of Follow-Up of More Than 775 000 Incidents , 2009, Circulation. Cardiovascular quality and outcomes.
[8] J. Murabito,et al. Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction , 2008, Circulation.
[9] Helen Y. Lee,et al. Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge , 2008, Journal of managed care pharmacy : JMCP.
[10] J. Gore,et al. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. , 2007, Archives of internal medicine.
[11] S. Normand,et al. An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With an Acute Myocardial Infarction , 2006, Circulation.
[12] L. Køber,et al. Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002 , 2005, Heart.
[13] O. Faergeman,et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. , 2005, JAMA.
[14] J. Gore,et al. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. , 2005, American heart journal.
[15] S. Yusuf,et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2005, JAMA.
[16] V. Gudnason,et al. The absolute risk of recurrent myocardial infarction is similar amongst both sexes: MONICA Iceland Study 1981–1999 , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[17] Harlan M Krumholz,et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the medicare health care quality improvement program. , 2003, Archives of internal medicine.
[18] V. Salomaa,et al. Trends in coronary events in Finland during 1983-1997. The FINAMI study. , 2003, European heart journal.
[19] Robert Parrish,et al. Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. , 2002, JAMA.
[20] A. Folsom,et al. Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996. , 2001, International journal of epidemiology.
[21] J. Gore,et al. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective. , 2001, American heart journal.
[22] M. Ezekowitz,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.
[23] M. Morice,et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.
[24] U. Goldbourt,et al. Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era--a national study. , 2001, American heart journal.
[25] W. Rogers,et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.
[26] A. Folsom,et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.
[27] V. Salomaa,et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. , 1996, Circulation.
[28] E. Peterson,et al. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. , 1994, JAMA.
[29] W. Rogers,et al. Race and Prognosis After Myocardial Infarction Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial , 1993, Circulation.
[30] C. Franklin,et al. Survival rates and prehospital delay during myocardial infarction among black persons. , 1986, The American journal of cardiology.
[31] R. Califf,et al. Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. , 2006, The American journal of medicine.
[32] M. Schroll,et al. Trends in incidence, case-fatality and recurrence of myocardial infarction in the Danish MONICA population 1982–1991 , 2004, European Journal of Epidemiology.
[33] Michael Miller. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[34] P. R. R. Ecurrent,et al. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .